Market Place
Sourcing Support
All News #Library
Biotech
Turn Therapeutics To Present At TD Cowen & Oppenheimer
09 Feb 2026 //
PHARMIWEB
Turn Therapeutics Reveals Corporate And Pipeline Updates
12 Jan 2026 //
PHARMIWEB
Turn Therapeutics Appoints Martin Dewhurst To Board Of Directors
07 Jan 2026 //
GLOBENEWSWIRE
Turn’s GX-03 Named Among Top Novel Atopic Dermatitis Mechanisms
11 Nov 2025 //
GLOBENEWSWIRE
Turn Therapeutics CEO Talks With Former CDC Director Dr Redfield
11 Nov 2025 //
GLOBENEWSWIRE
Turn Therapeutics Names Andrew VP Of Corporate Communications
04 Nov 2025 //
GLOBENEWSWIRE
Turn Therapeutics Enters Agreement with Medline
30 Oct 2025 //
GLOBENEWSWIRE
Turn Therapeutics Updates Shareholders on Clinical Progress
22 Oct 2025 //
GLOBENEWSWIRE
Turn Therapeutics Appoints Dr. Kent Kester To Board Of Directors
15 Oct 2025 //
GLOBENEWSWIRE
Turn Therapeutics Appoints Arthur Golden To Board Of Directors
14 Oct 2025 //
GLOBENEWSWIRE
Turn Therapeutics To Commence Trading Today On Nasdaq
08 Oct 2025 //
GLOBENEWSWIRE
Turn Therapeutics To Debut On Nasdaq Global Market
29 Sep 2025 //
BUSINESSWIRE
Turn Therapeutics` Investor Session Ahead of Nasdaq Listing
15 Sep 2025 //
BUSINESSWIRE
Turn Therapeutics` Intranasal Vaccine Shows Extended Stability
06 Aug 2025 //
BUSINESSWIRE
Turn Therapeutics Starts Eczema Trial With IL-36/IL-31 Drug
14 Jul 2025 //
BUSINESSWIRE
Turn Therapeutics Achieves Stability for Intranasal Live Vaccine
05 Feb 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.